2020-05630. National Institute of Allergy and Infectious Diseases; Notice of Closed Meetings  

  • Start Preamble

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings.

    The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel HHS-NIH-CDC-SBIR 2018-1 Phase II Topic 053: Effective Targeted Delivery of RNA-based Vaccines and Therapeutics.

    Date: April 15, 2020.

    Time: 2:00 p.m. to 5:00 p.m.

    Agenda: To review and evaluate contract proposals.

    Place: National Institute of Allergy and Infectious Diseases, National Institutes of Start Printed Page 15483Health, 5601 Fishers Lane, Room 3G22, Rockville, MD 20892 (Telephone Conference Call).

    Contact Person: Inka I Sastalla, Ph.D., Scientific Review Officer, Scientific Review Program, Division of Extramural Activities, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Room 3G22, Rockville, MD 20852, (301) 761-6431, inka.sastalla@nih.gov.

    Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel; HHS-NIH-CDC SBIR PHS 2018-1 Phase II Topic 052: High-Throughput Assay Platform for Quantifying Latent HIV Reservoirs.

    Date: April 21, 2020.

    Time: 2:00 p.m. to 5:00 p.m.

    Agenda: To review and evaluate contract proposals.

    Place: National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Room 3G22, Rockville, MD 20892 (Telephone Conference Call).

    Contact Person: Inka I Sastalla, Ph.D., Scientific Review Officer, Scientific Review Program, Division of Extramural Activities, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Room 3G22, Rockville, MD 20852, (301) 761-6431, inka.sastalla@nih.gov.

    (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS)

    Start Signature

    Dated: March 13, 2020.

    Miguelina Perez,

    Program Analyst, Office of Federal Advisory Committee Policy.

    End Signature End Preamble

    [FR Doc. 2020-05630 Filed 3-17-20; 8:45 am]

    BILLING CODE 4140-01-P

Document Information

Published:
03/18/2020
Department:
National Institutes of Health
Entry Type:
Notice
Document Number:
2020-05630
Dates:
April 15, 2020.
Pages:
15482-15483 (2 pages)
PDF File:
2020-05630.pdf